リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Methylation-mediated silencing of the LIM homeobox 6 (LHX6) gene promotes cell proliferation in human pancreatic cancer.」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Methylation-mediated silencing of the LIM homeobox 6 (LHX6) gene promotes cell proliferation in human pancreatic cancer.

Yakefuji Abudurexiti Zhaodi Gu Kanchan Chakma Tatsuo Hata Fuyuhiko Motoi Michiaki Unno Akira Horii Shinichi Fukushige 東北大学 DOI:10.1016/j.bbrc.2020.03.120

2020.06.04

概要

Epigenetic gene silencing by aberrant DNA methylation leads to loss of key cellular pathways in tumorigenesis. DNA methylation-mediated silenced genes in pancreatic cancer were searched for using the methyl-CpG targeted transcriptional activation (MeTA) method, and LHX6 (LIM homeobox 6), a transcription factor involved in embryogenesis and head development, was selected as a strong candidate gene. LHX6 was downregulated in most of the pancreatic cancer cell lines (83%, 10/12), mainly through promoter hypermethylation and histone deacetylation. Furthermore, LHX6 was methylated in primary pancreatic cancer specimens (57%, 16/28) in a tumor-specific manner. Re-expression of LHX6 inhibited colony formation and proliferation in LHX6 low-expressing pancreatic cancer cell lines, PK-1 and PK-9. In contrast, knockdown of LHX6 accelerated cell proliferation in LHX6 high-expressing pancreatic cancer cell lines, PCI-35 and MIA PaCa-2. In order to analyze LHX6 downstream genes, we performed microarray analyses using LHX6 inducible PK-1 and PK-9 and found that LHX6 induction upregulated several genes that had tumor suppressive functions. Among these, we focused on TFPI2 (Tissue factor pathway inhibitor-2) and found that TFPI2 was greatly downregulated in all twelve pancreatic cancer cell lines. Our present results suggest that epigenetic inactivation of LHX6 plays an important role in pancreatic tumorigenesis by promoting cell proliferation through aberrant transcriptional regulation of several cancer-related genes.

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

[1] Monitoring of Cancer Incidence in Japan - Survival 2006-2008 Report (Center for Cancer Control and Information Services, National Cancer Center, 2016).

[2] P. Ghaneh, E. Costello, J.P.Neoptolemos, Biology and management of pancreatic cancer, Gut 56 (2007) 134-1152, https://doi.org/10.1136/gut.2006.103333.

[3] L. Kunovsky, P. Tesarikova, Z. Kala, et al., The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer, Can. J. Gastroenterol. Hepatol. 2018 (2018) 5389820, https://doi.org/10.1155/2018/5389820.

[4] S. Fukushige, A. Horii, Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers, Cancer Lett. 342 (2014) 231-237, https://doi.org/10.1016/j.canlet.2012.03.022.

[5] S. Fukushige, E. Kondo, A. Horii, Methyl-CpG targeted transcriptional activation allows re- expression of tumor suppressor genes in human cancer cells, Biochem. Biophys. Res. Commun. 377 (2008) 600-605, https://doi.org/10.1016/j.bbrc.2008.10.016.

[6] Y. Sato, A. Horii, S. Fukushige, Microarray coupled with methyl-CpG targeted transcriptional activation (MeTA-array) identifies hypermethylated genes containing the stringent criteria of CpG islands at high frequency, Epigenetics 6 (2011) 752-759, https://doi.org/10.4161/epi.6.6.15906.

[7] S. Fukushige, E. Kondo, A. Horii, Methyl-CpG targeted recruitment of p300 reactivates tumor suppressor genes in human cancer cells, Biochem. Biophys. Res. Commun. 379 (2009) 1021-1026. https://doi.org/10.1016/j.bbrc.2009.01.010.

[8] H. Shimizu, A. Horii, M. Sunamura, et al., Identification of epigenetically silenced genes in human pancreatic cancer by a novel method “microarray coupled with methyl-CpG targeted transcriptional activation” (MeTA-array), Biochem. Biophys. Res. Commun. 411 (2011) 162-167, https://doi.org/10.1016/j.bbrc.2011.06.121.

[9] L. Yan, K. Cai, K. Sun, et al., MiR-1290 promotes proliferation, migration, and invasion of glioma cells by targeting LHX6, J. Cell Physiol. 233 (2018) 6621-6629, https://doi.org/10.1080/15592294.2015.1050173.

[10] Z. Hu, L. Xie, LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt/β-catenin signaling pathway, Mol. Med. Rep. 12 (2015) 4634-4639, https://doi.org/10.3892/mmr.2015.3997.

[11] W.B. Liu, X. Jiang, F. Han, et al., LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer, Cell Death Dis. 4 (2013) e882, https://doi.org/10.1038/cddis.2013.366.

[12] S. Jung, D. Jeong, J. Kim, et al., Epigenetic regulation of the potential tumor suppressor gene, hLHX6.1, in human cervical cancer, Int. J. Oncol. 38 (2011) 859-869, https://doi.org/10.3892/ijo.2011.904.

[13] M.R.H. Estécio, E.M. Youssef, P. Rahal, et al., LHX6 is a sensitive methylation marker in head and neck carcinomas, Oncogene 25 (2006) 5018-5026, https://doi.org/10.1038/sj.onc.1209509.

[14] C. Zhou, G. Yang, M. Chen, et al., Lhx6 and Lhx8: Cell fate regulators and beyond, FASEB J. 29 (2015) 4083-4091, https://doi.org/10.1096/fj.14-267500.

[15] J. Yang, F. Han, W. Liu, et al., LHX6, an independent prognostic factor, inhibits lung adenocarcinoma progression through transcriptional silencing of β-catenin, J. Cancer. 8 (2017) 2561-2574, https://doi.org/10.7150/JCA.19972.

[16] Q.J. Bi, X.J. Men, R. Han, G.L. Li, LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/AKT/mTOR signaling pathway, Eur. Rev. Med. Pharmacol. Sci. 22 (2018) 3067-3073, https://doi.org/10.26355/eurrev_201805_15066.

[17] Z. Gu, K. Inomata, K. Ishizawa, A. Horii, The FBXW7 β-form is suppressed in human glioma cells, Biochem. Biophys. Res. Commun. 354 (2007) 992-998, https://doi.org/10.1016/J.BBRC.2007.01.080.

[18] T. Furukawa, W.P. Duguid, L. Rosenberg, et al., Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16, Am. J. Pathol. 148 (1996) 1763-1770.

[19] Y. Saiki, Y. Yoshino, H. Fujimura, et al., DCK is frequently inactivated in acquired gemcitabine- resistant human cancer cells, Biochem. Biophys. Res. Commun. 421 (2012) 98-104, https://doi.org/10.1016/j.bbrc.2012.03.122.

[20] J.G. Herman, J.R. Graff, S. Myohanen, et al., Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 9821-9826, https://doi.org/10.1111/j.1442-200X.2011.03428.x.

[21] C.A. Schneider, W.S. Rasband, K.W. Eliceiri, NIH Image to ImageJ: 25 years of image analysis, Nat. Methods 9 (2012) 671–675, https://doi.org/10.1038/nmeth.2089.

[22] T. Hata, T. Furukawa, M. Sunamura, et al., RNA interference targeting aurora kinase A suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells, Cancer Res. 65 (2005) 2899-2905, https://doi.org/10.1158/0008-5472.CAN-04-3981.

[23] Y. Mizuguchi, Y. Saiki, A. Horii, S. Fukushige, Targeted TET oxidase activity through methyl- CpG-binding domain extensively suppresses cancer cell proliferation, Cancer Med. 5 (2016) 2522- 2533, https://doi.org/10.1002/cam4.830.

[24] E. Kondo, A. Horii, S. Fukushige, The human PMS2L proteins do not interact with hMLH1, a major DNA mismatch repair protein, J. Biochem. 125 (1999) 818-825.

[25] N. Chen, D. Sato, Y. Saiki, et al., S100A4 is frequently overexpressed in lung cancer cells and promotes cell growth and cell motility, Biochem. Biophys. Res. Commun. 447 (2014) 459-464, https://doi.org/10.1016/j.bbrc.2014.04.025.

[26] W.Y. Huang, S.D. Hsu, H.Y. Huang, et al., MethHC: A database of DNA methylation and gene expression in human cancer, Nucleic Acids Res. 43 (2015) D856-D861, https://doi.org/10.1093/nar/gku1151.

[27] K. Hibi, T. Goto, Y.H. Kitamura, et al., Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer, Anticancer Res. 30 (2010) 1205-1207.

[28] H. Matsubayashi, M. Canto, N. Sato, et al., DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease, Cancer Res. 66 (2006) 1208-1217, https://doi.org/10.1158/0008-5472.CAN-05-2664" https://doi.org/10.1158/0008-5472.CAN-05- 2664.

[29] H.Q. Chen, J. Zhao, Y. Li, et al., Epigenetic inactivation of LHX6 mediated microcystin-LR induced hepatocarcinogenesis via the Wnt/β-catenin and P53 signaling pathways, Environ. Pollut. 252 (2019) 216-226, https://doi.org/10.1016/j.envpol.2019.05.049.

[30] J.D. Cohen, Y. Wang, C. Douville, et al., Detection and localization of surgically resectable cancers with a multi-analyte blood test, Science 359 (2018) 926-930, https://doi.org/10.1126/science.aar3247.

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る